This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reid, St. P.
Right arrow Articles by Basler, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reid, St. P.
Right arrow Articles by Basler, C. F.

 Previous Article  |  Next Article 

Journal of Virology, December 2007, p. 13469-13477, Vol. 81, No. 24
0022-538X/07/$08.00+0     doi:10.1128/JVI.01097-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Ebola Virus VP24 Proteins Inhibit the Interaction of NPI-1 Subfamily Karyopherin {alpha} Proteins with Activated STAT1{triangledown}

St. Patrick Reid, Charalampos Valmas, Osvaldo Martinez, Freddy Mauricio Sanchez, and Christopher F. Basler*

Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029

Received 21 May 2007/ Accepted 24 September 2007

The Zaire ebolavirus protein VP24 was previously demonstrated to inhibit alpha/beta interferon (IFN-{alpha}/ß)- and IFN-{gamma}-induced nuclear accumulation of tyrosine-phosphorylated STAT1 (PY-STAT1) and to inhibit IFN-{alpha}/ß- and IFN-{gamma}-induced gene expression. These properties correlated with the ability of VP24 to interact with the nuclear localization signal receptor for PY-STAT1, karyopherin {alpha}1. Here, VP24 is demonstrated to interact not only with overexpressed but also with endogenous karyopherin {alpha}1. Mutational analysis demonstrated that VP24 binds within the PY-STAT1 binding region located in the C terminus of karyopherin {alpha}1. In addition, VP24 was found to inhibit PY-STAT1 binding to both overexpressed and endogenous karyopherin {alpha}1. We assessed the binding of both PY-STAT1 and the VP24 proteins from Zaire, mouse-adapted Zaire, and Reston Ebola viruses for interaction with all six members of the human karyopherin {alpha} family. We found, in contrast to previous studies, that PY-STAT1 can interact not only with karyopherin {alpha}1 but also with karyopherins {alpha}5 and {alpha}6, which together comprise the NPI-1 subfamily of karyopherin {alpha}s. Similarly, all three VP24s bound and inhibited PY-STAT1 interaction with karyopherins {alpha}1, {alpha}5, and {alpha}6. Consistent with their ability to inhibit the karyopherin-PY-STAT1 interaction, Zaire, mouse-adapted Zaire, and Reston Ebola virus VP24s displayed similar capacities to inhibit IFN-ß-induced gene expression in human and mouse cells. These findings suggest that VP24 inhibits interaction of PY-STAT1 with karyopherins {alpha}1, {alpha}5, or {alpha}6 by binding within the PY-STAT1 binding region of the karyopherins and that this function is conserved among the VP24 proteins of different Ebola virus species.


* Corresponding author. Mailing address: Department of Microbiology, Box 1124, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029. Phone: (212) 241-4847. Fax: (212) 534-1684. E-mail: chris.basler{at}mssm.edu

{triangledown} Published ahead of print on 10 October 2007.


Journal of Virology, December 2007, p. 13469-13477, Vol. 81, No. 24
0022-538X/07/$08.00+0     doi:10.1128/JVI.01097-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Swenson, D. L., Warfield, K. L., Warren, T. K., Lovejoy, C., Hassinger, J. N., Ruthel, G., Blouch, R. E., Moulton, H. M., Weller, D. D., Iversen, P. L., Bavari, S. (2009). Chemical Modifications of Antisense Morpholino Oligomers Enhance Their Efficacy against Ebola Virus Infection. Antimicrob. Agents Chemother. 53: 2089-2099 [Abstract] [Full Text]  
  • Prins, K. C., Cardenas, W. B., Basler, C. F. (2009). Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKK{varepsilon} and TBK-1. J. Virol. 83: 3069-3077 [Abstract] [Full Text]